A Case of the Cauda Equina Syndrome Associated With the Intrathecal Chemotherapy in a Patient With Primary Central Nervous System Lymphoma.
10.5535/arm.2013.37.3.420
- Author:
Seunglee PARK
1
;
Jung Il KANG
;
Hyun BANG
;
Bo Ram KIM
;
Jongmin LEE
Author Information
1. Department of Rehabilitation Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea. leej@kuh.ac.kr
- Publication Type:Case Report
- Keywords:
Cauda equina syndrome;
Chemotherapy;
Intrathecal injections
- MeSH:
Cauda Equina;
Central Nervous System;
Cytarabine;
Humans;
Injections, Spinal;
Lymphoma;
Lymphoma, B-Cell;
Methotrexate;
Polyradiculopathy;
Urodynamics
- From:Annals of Rehabilitation Medicine
2013;37(3):420-425
- CountryRepublic of Korea
- Language:English
-
Abstract:
The intrathecal chemotherapy with methotrexate and cytarabine arabinoside is used for the treatment and prophylaxis of the primary central nervous system lymphoma. The therapy may induce neurotoxicity including the cauda equina syndrome. We report a case of a 58-year-old man with the diffuse large B-cell lymphoma, who developed the cauda equina syndrome after the administration of intrathecal methotrexate and cytarabine arabinoside, as diagnosed by the electrodiagnostic, urodynamic, and radiologic approaches.
